Research and Markets


Printer Friendly

Printed from http://www.researchandmarkets.com/reports/226222


Heterocyclic Compounds - Industry Patent Mapping Report


Description: Preparation, separation, purification, or stabilization of unsubstituted lactams; Heterocyclic compounds containing three-member rings with one nitrogen atom as the only ring hetero atom; Heterocyclic compounds containing four-member rings with one nitrogen atom as the only ring hetero atom; Heterocyclic compounds containing five-member rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom; Heterocyclic compounds containing five-member rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom; Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings; Heterocyclic compounds containing six-member rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members; Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems; Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems; Heterocyclic compounds containing acridine or hydrogenated acridine ring systems; Heterocyclic compounds containing six-member rings having one nitrogen atom as the only ring hetero atom; Heterocyclic compounds containing seven-member rings having one nitrogen atom as the only ring hetero atom; Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom; Heterocyclic compounds containing rings of less than five members having two nitrogen atoms as the only ring hetero atoms; Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings; Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings; Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings; Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings; Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings; Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings; Heterocyclic compounds containing seven-member rings having two nitrogen atoms as the only ring hetero atoms; Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms; Heterocyclic compounds containing five-member rings having three nitrogen atoms as the only ring hetero atoms; Heterocyclic compounds containing 1,3,5-triazine rings; Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms; Heterocyclic compounds containing rings having more than four nitrogen atoms as the only ring hetero atoms; Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings; Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings; Heterocyclic compounds containing six-member rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms; Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms;  Heterocyclic compounds containing five-member rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms; Heterocyclic compounds containing 1, 2-thiazole or hydrogenated 1,2-thiazole rings; Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings; Heterocyclic compounds containing six-member rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms; Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms; Heterocyclic compounds containing rings having nitrogen, oxygen and sulfur atoms as the only ring hetero atoms; Heterocyclic compounds containing rings having nitrogen and selenium or nitrogen and tellurium, with or without oxygen or sulfur atoms, as the ring hetero atoms; Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo  nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms; Preparation of oxiranes; Compounds containing three-member rings having one oxygen atom as the only ring hetero atom; Heterocyclic compounds containing four-member rings having one oxygen atom as the only ring hetero atoms; Heterocyclic compounds containing five-member rings having one oxygen atom as the only ring hetero atom; Heterocyclic compounds containing six-member rings having one oxygen atom as the only ring hetero atom, not condensed with other rings; Heterocyclic compounds containing six-member rings having one oxygen atom as the only hetero atom, condensed with other rings; Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom; Heterocyclic compounds containing five-member rings having two oxygen atoms as the only ring hetero atoms; Heterocyclic compounds containing six-member rings having two oxygen atoms as the only ring hetero atoms; Heterocyclic compounds containing more than two oxygen atoms as the only ring hetero atoms; Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms; Heterocyclic compounds containing rings having oxygen and selenium or oxygen and tellurium atoms as the only ring hetero atoms; Heterocyclic compounds containing rings of less than five members, having one sulfur atom as the only ring hetero atom; Heterocyclic compounds containing five-member rings having one sulfur atom as the only ring hetero atom; Heterocyclic compounds containing six-member rings having one sulfur atom as the only ring hetero atom; Heterocyclic compounds containing rings of more than six members having one sulfur atom as the only ring hetero atom; Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms; Heterocyclic compounds containing rings having three or more sulfur atoms as the only ring hetero atoms; Heterocyclic compounds containing rings having sulfur and selenium or sulfur and tellurium atoms as the only ring hetero atoms; Heterocyclic compounds containing rings having selenium or tellurium atoms as the only ring hetero atoms; Heterocyclic compounds containing rings having halogen atoms as ring hetero atoms; Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-member ring with only one nitrogen atom;  Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom;  Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms; Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms; Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms; Heterocyclic compounds containing the thiamine skeleton; Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms; Heterocyclic compounds containing two or more hetero rings, at least one ring having selenium, tellurium, or halogen atoms as ring hetero atoms; Heterocyclic compounds containing 8-azabicyclo  octane, 9-azabicyclo  nonane, or 3-oxa-9-azatricyclo  nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof; Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids; Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo  quinolizines, e.g. berberine; Heterocyclic compounds containing indolo  quinoline ring systems, e.g. derivatives of ergoline; Heterocyclic compounds containing benz indolo  quinolizine ring systems, e.g. yohimbine; 16, 18-lactones thereof, e.g. reserpic acid lactone; Heterocyclic compounds containing indolo  pyrido-naphthyridine ring systems, e.g. vincamine; Heterocyclic compounds containing 1-azabicyclo  octane ring systems, i.e. compounds containing a ring system of the formula: , e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring; Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-member ring with one nitrogen atom, not provided for by groups C07D451/00 to C07D463/00; Heterocyclic compounds containing purine ring systems; Heterocyclic compounds containing pteridine ring systems; Heterocyclic compounds containing 1-azabicyclo  heptane ring systems, i.e. compounds containing a ring system of the formula: , e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring; Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro  furan ring systems, e.g. derivatives of -morphinan of the formula; Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system; Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms; Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms; Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms; Heterocyclic compounds containing 4-thia-1-azabicyclo  heptane ring systems, i.e. compounds containing a ring system of the formula: , e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring; Heterocyclic compounds containing 5-thia-1-azabicyclo  octane ring systems, i.e. compounds containing a ring system of the formula: , e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring; Heterocyclic compounds containing 4-oxa-1-azabicyclo  heptane ring systems, i.e. compounds containing a ring system of the formula: , e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring; Heterocyclic compounds containing 5-oxa-1-azabicyclo  octane ring systems, i.e. compounds containing a ring system of the formula: , e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring; Such ring systems being further condensed; Heterocyclic compounds containing in the condensed system at least one hetero ring having selenium, tellurium, or halogen atoms as ring hetero atoms; Heterocyclic compounds containing unspecified hetero rings. [20,000 Patents]

Our range of Patent Maps act as a Patent Information Encyclopedia, providing a High-level Summary of Patent Information on patenting activity in various technologies and industries. Organized into an intuitive graphical layout, they highlight a wide array of information on technology gaps and white spaces and trends in patent filings.

Our reports will be of immense value to both the management and research groups in organizations. The data has been presented in a user-friendly manner that attempts to summarize patent intelligence concisely, while retaining comprehensiveness of scope and depth. As such, users will be able to use the information obtained from the reports instantaneously for strategic and operational decision-making, and without the need to invest in further processing.

We offer a range of Patent Mapping reports

1. Our Industry Patent Mapping Reports are an excellent aid for technology researchers, enabling then to understand the top players, top sub-technology and the significant invention in a particular field. Also, business researchers can understand the top players in the market, facilitating the mapping to those with large industry market share. Finally, For those performing due diligence on a particular technology areas, the reports allow them to determine the pace of innovation

2. Our Country Patent Mapping reports will assist business researchers in understanding the top players within a specific country. They are also a valuable resource for economists, striving to understand which are the dominant innovative companies in a particular country, facilitating further benchmarking and comparative studies.

3. Our company Patent Mapping Reports provide specific and detailed insights into patenting activities of specific Fortune 500, NASDAQ and S&P 500 organisations.

About Patents:
The International Patent Classification (IPC) is a hierarchical system in which the whole area of technology is divided into a range of sections, classes, subclasses and groups. This system is indispensable for the retrieval of patent documents in the search for establishing the novelty of an invention or determining the state of the art in a particular area of technology. US Patent Classification UPC classify a patent according to all information in patent specification while IPC classify a patent according to only patent claims. UPC stresses on the function of intrinsic characteristics of product or processing.

As IPC or UPC are not viable in themselves for assigning an invention to an industry, because they focus specifically on the technology, not on industries that may manufacture or use the technology, it is necessary to assign inventions to industries.

We have undertaken a concordance (matching) of IPC (International Patent Classification ) and (US Patent Classification) UPC to NAICS (North American Industrial Classification System -this new, uniform, industry-wide classification system has been designed as the index for statistical reporting of all economic activities of the U.S., Canada, and Mexico). This extensive exercise assigns patent classifications to industries based on NAICS codes. The results are summarized in the following categories:

- Primary Industries: Agribusiness, Fishing and Forestry, Mining

- Secondary Industries: Construction, Food & Accessory Manufacturing, Metal & Machinery Manufacturing, Electronic Goods Manufacturing, Miscellaneous Manufacturing

- Tertiary Industries: Wholesale & Retailing, Transportation, Services

- Quarternary & Quinary Industries: Information & Research, Health & Education, Cultural & Entertainment, Personal & Others


Contents:

1. Assignee Patent Map
2. Assignee Country Patent Map
3. Attorney-Agent-Firm Patent Map
4. Application/Filing Year Patent Map
5. Inventor Patent Map
6.Technology Class (IPC) Patent Map
7. Sub-Technology (IPC) Patent Map
8. Publication/Grant Year Patent Map
9. Priority Year Patent Map
10. Technology Class (UPC) Patent Map
11. Sub-Technology (UPC) Patent Map
12. Backward Citation Patent Map
13. Forward Citation Patent Map




Ordering: Order Online - visit http://www.researchandmarkets.com/reports/226222

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


Research and Markets Page 1 of 2
Printed 05/09/2008 17:00:03
Fax Order Form

To place an order via fax simply print this form, fill in the information below and fax the completed form to the number at the bottom of this page. If you have any questions please email help@researchandmarkets.com


Order information

Please verify that the product information is correct and select the format you require.

Product Name:
Heterocyclic Compounds - Industry Patent Mapping Report
Web Address:
http://www.researchandmarkets.com/reports/226222
Office Code:
OCHHGKOQMQZ

Report formats

Please enter the quantity of the report format you require.

Format Quantity Price
Electronic €128.00




Contact information

Please enter all the information below in BLOCK CAPITALS.

First Name:   Last Name:  
Email Address:
Job Title:
Organisation:
Address:
City:
Postal/Zip Code:
Country:
Phone Number:
Fax Number:


Please fax this form to:
(646) 607-1907 or (646) 964-6609 - From USA
+353 1 481 1716 or +353 1 653 1571 - From Rest of World

Research and Markets Page 2 of 2
Printed 05/09/2008 17:00:03

Payment information

Please indicate the payment method you would like to use by selecting the appropriate box.

 Pay by Credit Card:
American Express
Diners Club
Master Card
Visa
Cardholder Name:
Expiry Date: /
Card Number:
CVV Security Code:
Issue Date: /   (Diners Club only)


 Pay by Check:
Please post the check, accompanied by this form, to:

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


 Pay by Wire Transfer:
Please transfer funds to:

Account number: 83313083
Sort code: 98-53-30
Swift code: ULSBIE2D
IBAN number: IE78ULSB98533083313083
Bank Address: Ulster Bank,
27-35 Main St,
Blackrock,
Co. Dublin,
Ireland.


If you have a Marketing Code please enter it below:

Marketing Code:


Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp



Please fax this form to:
(646) 607-1907 or (646) 964-6609 - From USA
+353 1 481 1716 or +353 1 653 1571 - From Rest of World